Skip to main content

Table 2 Basic clinical characteristics of 2965 participants

From: The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy

Variable

Hp 1 Carriers

Hp 2-2

P value

Number

1371

1594

–

Age (years)

61.3 ± 11.8

61.9 ± 11.9

0.126

Male/female (n)

727 / 644

803 / 791

0.150

Body mass index (kg/m2)

24.6 ± 6.1

24.5 ± 3.6

0.834

Systolic blood pressure (mmHg)

130 (120, 145)

130 (120, 150)

0.718

Diastolic blood pressure (mmHg)

80 (74, 90)

80 (75, 90)

0.097

Duration of diabetes (years)

7.0 (2.0, 12.0)

7.0 (2.0, 12.0)

0.840

HbA1c (%)

9.1 ± 2.2

9.0 ± 2.2

0.376

HbA1c [mmol/mol]

75.0 ± 24.0

74.0 ± 24.0

Total cholesterol (mmol/L)

4.6 (3.9, 5.3)

4.7 (4.2, 5.5)

< 0.001

Triglycerides (mmol/L)

1.4 (1.0, 2.1)

1.5 (1.0, 2.1)

0.115

HDL-C (mmol/L)

1.1 (0.9, 1.3)

1.1 (0.9, 1.3)

0.087

LDL-C (mmol/L)

2.9 (2.4, 3.5)

3.0 (2.5, 3.6)

< 0.001

Diabetic macroangiopathy disease

1018 (74.3%)

1187 (74.5%)

0.894

  1. Data are shown as n (%), mean ± standard deviation, or median (interquartile range)
  2. Hp haptoglobin, Hp 1 carriers Hp 1-1 and Hp 2-1, HbA1c hemoglobin A1c, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol